Medicare Enrolled
Dr. Nora Maczura, MD
Gynecologic Oncology Physician · Springfield, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Maczura from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maczura?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Maczura
Dr. Nora Maczura is a gynecologic oncology physician in Springfield, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Maczura performed 63,149 Medicare services across 1,078 unique beneficiaries.
Between the years covered by Open Payments, Dr. Maczura received a total of $2,450 from 10 pharmaceutical and/or device companies across 19 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gynecologic oncology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Maczura is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in IL
$2,450 industry payments
Medicare Practice Summary
Medicare Utilization ↗63,149
Medicare services
Top 3% in IL for gynecologic oncology physician
1,078
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,324 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
21,900 | $0 | $4 |
| Paclitaxel chemotherapy injection | 17,521 | $0 | $1 |
| Pembrolizumab injection (Keytruda) | 11,200 | $43 | $99 |
| Bevacizumab-bvzr biosimilar injection, 10 mg An injection of bevacizumab-bvzr, a biosimilar medication, administered in a 10 mg dose. |
4,721 | $24 | $156 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,916 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,340 | $1 | $79 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
581 | $2 | $16 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
388 | $12 | $88 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
377 | $2 | $7 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
360 | $1 | $5 |
| Injection, potassium chloride, per 2 meq | 340 | $0 | $2 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
304 | $1 | $4 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
245 | $96 | $555 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
244 | $2 | $5 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
185 | $6 | $6 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
185 | $96 | $679 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
169 | $8 | $82 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
161 | $21 | $155 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
156 | $59 | $382 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
133 | $48 | $319 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
129 | $21 | $149 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
110 | $1 | $2 |
| Basic blood chemical test (calcium, ionized) A blood test that measures basic chemical levels, specifically including calcium and ionized calcium. |
106 | $13 | $118 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
103 | $1 | $10 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
62 | $121 | $741 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
43 | $15 | $98 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
37 | $38 | $178 |
| Laparoscopic hysterectomy with salpingo-oophorectomy, 250g or less Surgical removal of the uterus, fallopian tubes, and/or ovaries through small abdominal incisions using a camera-guided instrument. The procedure is specified for cases where the removed tissue weighs 250 grams or less. |
32 | $702 | $5,828 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
31 | $5 | $58 |
| Endoscopic biopsy and removal of abdominal lymph nodes A procedure to examine and remove lymph nodes in the abdominal cavity using an endoscope. The endoscope allows the provider to access the area through a small incision. |
19 | $206 | $2,868 |
| Intraoperative lymph node imaging Imaging performed during surgery to visualize lymph nodes. |
19 | $162 | $1,453 |
| Pap test, manual screening A laboratory test in which a healthcare provider manually examines a sample of cells from the cervix under a microscope to check for abnormalities. |
18 | $20 | $22 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
14 | $96 | $624 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.8% high complexity
96.4% medium
1.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,450
Total received (2018-2024)
Avg $408/year across 6 years
Top 42% in IL for gynecologic oncology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
10
Companies
19
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,428 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$22 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$675
2023
$34
2022
$1,152
2021
$125
2019
$295
2018
$169
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Stryker Corporation
$639
Eisai Inc.
$21
Myriad Genetic Laboratories, Inc.
$15
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Memic Innovative Surgery Inc.
$1,046
Stryker Corporation
$639
TESARO, Inc.
$240
AstraZeneca Pharmaceuticals LP
$231
Clovis Oncology, Inc.
$119
Kerecis Limited
$84
Eisai Inc.
$41
EISAI INC.
$22
Myriad Genetic Laboratories, Inc.
$15
Genmab U.S., Inc.
$14
Top 3 companies account for 78.6% of all-time payments
Associated products mentioned in payments ›
1788 · Anovo Surgical System · Kerecis Omega3 SurgiClose · LYNPARZA · Lenvima · MYRISK · Rubraca · Tivdak · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gynecologic oncology physicians within 10 mi
3
Per 100K population
1.5
County median income
$74,114
Nearest hospital
MEMORIAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Maczura is a mixed practice specialist, with above-average Medicare volume (top 3% in IL), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Maczura experienced with anti-nausea injection (fosaprepitant)?
Based on Medicare claims data, Dr. Maczura performed 21,900 anti-nausea injection (fosaprepitant) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Maczura receive payments from pharmaceutical companies?
Yes. Dr. Maczura received a total of $2,450 from 10 companies across 19 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maczura's costs compare to other gynecologic oncology physicians in Springfield?
Dr. Maczura's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maczura) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Gynecologic Oncology Physicians in Springfield
Browse gynecologic oncology physicians in Springfield ranked by procedure volume and transparency data.
Highest volume
Top Gynecologic Oncology Physicians in IL
Gynecologic oncology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gynecologic Oncology Physicians in IL
Which IL gynecologic oncology physicians receive the most from drug and device companies.
By company
Memic Innovative Surgery Inc. Payments to Doctors
See all physicians who received payments from Memic Innovative Surgery Inc.
By company
Stryker Corporation Payments to Doctors
See all physicians who received payments from Stryker Corporation.
By company
TESARO, Inc. Payments to Doctors
See all physicians who received payments from TESARO, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology